Anebulo Pharmaceuticals, Inc. (ANEB) — DEF 14A Filings
All DEF 14A filings from Anebulo Pharmaceuticals, Inc.. Browse 1 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (1)
-
Anebulo Pharmaceuticals Files Definitive Proxy Statement
— Mar 6, 2025 Risk: low
Anebulo Pharmaceuticals, Inc. filed its definitive proxy statement (DEF 14A) on March 6, 2025. This filing is related to the company's annual meeting and outlin
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX